Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T G Eisen

Showing results (1-10 of 9) with videos related to

Pageof 1
Sort By:
Melanoma Research|August 1, 1996
The control of gene expression in melanocytes and melanomasT G Eisen
Oncology (Williston Park, N.Y.)|February 24, 2001
Thalidomide in solid tumors: the London experienceT G Eisen
Melanoma Research|July 26, 2002
Differentiation of human melanoma cells through p38 MAP kinase is associated with decreased retinoblastoma protein phosphorylation and cell cycle arrestK S M Smalley, T G Eisen
European Journal of Cancer (Oxford, England : 1990)|April 5, 2015
The power of phase II end-points for different possible mechanisms of action of an experimental treatmentJ M S Wason, A Dentamaro, T G Eisen
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 1, 2002
Unexpected toxicity of combination thalidomide and interferon alpha-2a treatment in metastatic renal cell carcinomaP D Nathan, M E Gore, T G Eisen
British Journal of Cancer|August 12, 2004
A prognostic index that predicts outcome following palliative whole brain radiotherapy for patients with metastatic malignant melanomaS L Morris, S H Low, R P A'Hern, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|July 19, 2002
A randomised phase II study of conventional versus accelerated infusional chemotherapy with granulocyte colony-stimulating factor support in advanced breast cancerR H De Boer, T G Eisen, P A Ellis, et al.
British Journal of Cancer|December 6, 2006
A phase I/II study of lomustine and temozolomide in patients with cerebral metastases from malignant melanomaJ M G Larkin, S A Hughes, D A Beirne, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 31, 2004
Gemcitabine plus carboplatin versus mitomycin, ifosfamide, and cisplatin in patients with stage IIIB or IV non-small-cell lung cancer: a phase III randomized study of the London Lung Cancer GroupR M Rudd, N H Gower, S G Spiro, et al.
Pageof 1

Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
Melanoma Research|August 1, 1996
The control of gene expression in melanocytes and melanomasT G Eisen
Oncology (Williston Park, N.Y.)|February 24, 2001
Thalidomide in solid tumors: the London experienceT G Eisen
Melanoma Research|July 26, 2002
Differentiation of human melanoma cells through p38 MAP kinase is associated with decreased retinoblastoma protein phosphorylation and cell cycle arrestK S M Smalley, T G Eisen
European Journal of Cancer (Oxford, England : 1990)|April 5, 2015
The power of phase II end-points for different possible mechanisms of action of an experimental treatmentJ M S Wason, A Dentamaro, T G Eisen
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 1, 2002
Unexpected toxicity of combination thalidomide and interferon alpha-2a treatment in metastatic renal cell carcinomaP D Nathan, M E Gore, T G Eisen
British Journal of Cancer|August 12, 2004
A prognostic index that predicts outcome following palliative whole brain radiotherapy for patients with metastatic malignant melanomaS L Morris, S H Low, R P A'Hern, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|July 19, 2002
A randomised phase II study of conventional versus accelerated infusional chemotherapy with granulocyte colony-stimulating factor support in advanced breast cancerR H De Boer, T G Eisen, P A Ellis, et al.
British Journal of Cancer|December 6, 2006
A phase I/II study of lomustine and temozolomide in patients with cerebral metastases from malignant melanomaJ M G Larkin, S A Hughes, D A Beirne, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 31, 2004
Gemcitabine plus carboplatin versus mitomycin, ifosfamide, and cisplatin in patients with stage IIIB or IV non-small-cell lung cancer: a phase III randomized study of the London Lung Cancer GroupR M Rudd, N H Gower, S G Spiro, et al.
Pageof 1